Toggle navigation
Home
Search
Services
Blog
Contact
About
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
Wayne State University, Detroit, MI, United States
Search grants from Wayne State University
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Functional Characterization of BAFF-induced Genes
Hormonal Evaluation and Genomic Analysis of Combined Pituitary Hormone Deficiency
Abt 378/Ritonavir Plus Stavudine and Lamivudine in HIV Infected Subjects
Phase Ib Trial of Intravenous Anti-CD3 Monoclonal Antibody
Vitamin D Kinetics
Recently added grants:
Proteomics Study of Non-viral Related Hepatocellular Carcinoma Risk
Saturation genome editing approach to functionally test all possible MSH2 variants
A Molecular Study of Rag GTPase-Dependent Amino Acid Sensing
FoXM1 inhibition: a novel therapeutic avenue to treat breast cancers
A Wireless Multi-function Microscope for Lifetime Imaging of the Brain Tumor Vasculome
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN005022-001
Application #
6994809
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Wayne State University
Department
Type
DUNS #
City
Detroit
State
MI
Country
United States
Zip Code
48202
Related projects
NIH 2006
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2004
N01 CN
PHASE II CLINIAL TRIAL OF NEW CHEMOPREVENTIVE AGENTS - WSn68 - ZILEUT-261005022
/ Wayne State University
NIH 2000
N01 CN
Phase II Clinial Trial of New Chemopreventive Agents - W
Kucuk, Omer / Wayne State University
$758,959
Comments
Be the first to comment on this grant